NGN-401

Neurogene drops high-dose arm in Rett study after death
Pharmaphorum
Fri, 11/22/24 - 11:09 am
Neurogene
clinical trials
Rett Syndrome
patient death
gene therapy
NGN-401
Neurogene secures $200M ahead of anticipated study readout
BioPharma Dive
Mon, 11/4/24 - 06:55 pm
Neurogene
funding
Rett Syndrome
NGN-401